4.3 Editorial Material

Immunosuppression for interstitial lung disease in systemic sclerosis - novel insights and opportunities for translational research

Related references

Note: Only part of the references are listed.
Letter Rheumatology

Observational Data to Study Medication Outcomes in Systemic Sclerosis

Marie Hudson et al.

JOURNAL OF RHEUMATOLOGY (2011)

Article Critical Care Medicine

Interstitial lung disease in systemic sclerosis - A simple staging system

Nicole S. L. Goh et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Urology & Nephrology

The effect of epoetin dose on hematocrit

D. Cotter et al.

KIDNEY INTERNATIONAL (2008)

Editorial Material Medicine, General & Internal

De testimonio: on the evidence for decisions about the use of therapeutic interventions

Michael Rawlins

LANCET (2008)

Review Rheumatology

Incidence and prevalence of systemic sclerosis: A systematic literature review

Helene Chifflot et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2008)

Article Rheumatology

Changes in causes of death in systemic sclerosis, 1972-2002

Virginia D. Steen et al.

ANNALS OF THE RHEUMATIC DISEASES (2007)

Article Rheumatology

Scleroderma lung: Initial forced vital capacity as predictor of pulmonary function decline

Sotiris C. Plastiras et al.

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)

Article Medicine, General & Internal

Cyclophosphamide versus placebo in scleroderma lung disease

Donald P. Tashkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

A national evaluation of the effect of trauma-center care on mortality

EJ MacKenzie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Rheumatology

Interstitial lung disease in scleroderma

B White

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2003)

Article Mathematical & Computational Biology

Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures

MA Hernán et al.

STATISTICS IN MEDICINE (2002)

Article Statistics & Probability

Marginal structural models to estimate the joint causal effect of nonrandomized treatments

MA Hernán et al.

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2001)